Cite
HARVARD Citation
Mirza, M. et al. (n.d.). Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial. International journal of gynecological cancer. pp. A15-A16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mirza, M. et al. (n.d.). Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial. International journal of gynecological cancer. pp. A15-A16. [Online].